Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 20, 2020
Previous Article Next Article

Injectable DNA-architected nanoraspberry depot-mediated on-demand programmable refilling and release drug delivery

Author affiliations

Abstract

Drug delivery depots boosting a local concentration of therapeutic agents have received great attention in clinical applications due to their low occurrence of side effects and high therapeutic efficacy. However, once the payload is exhausted, the local drug concentration will be lower than the therapeutic window. To address this issue, an injectable double-strand deoxyribonucleic acid (DNA)-architected nanoraspberry depot (DNR-depot) was developed that can refill doxorubicin (Dox, an anticancer drug) from the blood and remotely control drug release on demand. The large porous surface on a uniform nanoraspberry (NR) filled covalently with DNA serves as a Dox sponge-like refilling reservoir, and the NR serves as a magnetic electrical absorber. Via the strong affinity between Dox and DNA molecules, the refilling process of Dox can be achieved on DNR-depot both in vitro and in vivo. Upon high-frequency magnetic field (HFMF) treatment, the remotely triggered release of Dox is actuated by the dissociation of Dox and DNA molecules, facilitating an approximately 800% improvement in drug concentration at the tumor site compared to free Dox injection alone. Furthermore, the cycles of refilling and release can be carried out more than 3 times in vivo within 21 days. The combination of refilling and HFMF-programmable Dox release in tumors via DNR-depot can effectively inhibit tumor growth for 30 days.

Graphical abstract: Injectable DNA-architected nanoraspberry depot-mediated on-demand programmable refilling and release drug delivery

Back to tab navigation

Supplementary files

Article information


Submitted
11 Feb 2020
Accepted
02 May 2020
First published
04 May 2020

Nanoscale, 2020,12, 11153-11164
Article type
Paper

Injectable DNA-architected nanoraspberry depot-mediated on-demand programmable refilling and release drug delivery

R. Hsu, J. Fang, W. Shen, Y. Sheu, C. Su, W. Chiang and S. Hu, Nanoscale, 2020, 12, 11153
DOI: 10.1039/D0NR01185A

Social activity

Search articles by author

Spotlight

Advertisements